A patent review on strategies for biological control of mosquito vector,World Journal of Microbiology and Biotechnology

当前位置： X-MOL 学术 › World J. Microbiol. Biotechnol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

A patent review on strategies for biological control of mosquito vector
World Journal of Microbiology and Biotechnology ( IF 4.1 ) Pub Date : 2020-11-24 , DOI: 10.1007/s11274-020-02960-w
Kashmira Parihar ₁ , Manasi Telang ₁ , Ankita Ovhal ₁

Affiliation

Mosquitoes are the vectors responsible for transmitting serious and life-threatening diseases such as malaria, dengue, yellow fever, chikungunya and lymphatic filariasis. Very few effective vaccines or drugs have been developed so far to prevent or treat these diseases, highlighting a need for vector control. This paper presents a comprehensive technology overview of patent documents disclosing biological agents for mosquito control. The patent analysis revealed that comparable number of patent documents were filed in two technology categories: non-recombinant agents and genetically modified (GM) agents. In the category of non-recombinant agents, toxic peptides from microbes and biological consortia seemed to be the earliest technology noted right from the year 1965 whereas the patent filings for suppression of mosquito population using genetic modification techniques have emerged from the year 2000 onwards. The United States of America is the leading patent filing jurisdiction followed by China and the Great Britain. Academic institutes have filed higher number of patent applications as compared to private companies. University of Florida was found to be the leading patent filing entity and its patents were focused on suppression of vector population using techniques such as release of insects with dominant lethal (RIDL) and RNA interference (RNAi).

更新日期：2020-11-24

点击分享查看原文

点击收藏

阅读更多本刊最新论文

全部期刊列表>>